Treating Patients with Aripiprazol: A Safe Gamble?

INTRODUCTION: Aripiprazole (ARI) is an atypical antipsychotic drug with D2 partial agonist properties, usually prescribed to treat mood disorders (major depression or bipolar disorder) and schizophrenic disorder (schizophrenia or schizoaffective disorder). Dopamine receptor agonists, as is ARI, have...

Descripción completa

Detalles Bibliográficos
Autores principales: Leal, B., Vila-Chã, D., Garcia, S., Pinto, I., Mateiro, R., Avelino, M., Martins, M., Salgado, J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2022
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9567850/
http://dx.doi.org/10.1192/j.eurpsy.2022.1838

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9567850/
http://dx.doi.org/10.1192/j.eurpsy.2022.1838

Ejemplares similares